CBIO Financials

Crescent Biopharma, Inc. - Financial statements & key metrics

Stock Price

$18.66

Market Cap

$491.31M

Balance Sheet Highlights

Total Assets

$11.09M

Total Liabilities

$5.78M

Shareholders Equity

Cash & Equivalents

$10.72M

Total Debt

Cash Flow Highlights

Operating Cash Flow

$-31.10M

CapEx

Free Cash Flow

Profitability Metrics

000

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is CBIO revenue?

View CBIO's income statement for detailed revenue data.

Is CBIO profitable?

Check CBIO's income statement for profitability data.

What is CBIO market cap?

CBIO has a market capitalization of $491.31M, making it a small-cap stock.

Does CBIO have debt?

View CBIO's balance sheet for debt information.

What is CBIO cash flow?

Cash flow data is available in the full financial statements.